Browsing: Association

The American Nutrition Association (ANA) calls for the wider use of evidence-based biomarkers in personalized nutrition care to manage chronic diseases. It highlights the potential of a new real-time biomarker test for metabolic health based on a blood sample drawn from a finger prick. However, the organization tells us policy changes and medical nutrition training…

Borderline personality disorder (BPD) is a severe mental health condition influenced by environmental risk factors (for example, interpersonal trauma) and genetic factors. We conducted the largest genome-wide association study (GWAS) meta-analysis of BPD so far, with a discovery sample of 12,339 cases and 1,041,717 controls, and a replication study of 685 cases and 107,750 controls…

School Nutrition Association Annual National Conference Features Exhibits, Education Sessions and Demos

The U.S. Pointer Study, a two-year landmark clinical trial, enrolled more than 2,000 people at risk for Alzheimer’s disease, looking at lifestyle changes and its affect on brain health

The Alzheimer’s Association has launched a new global clinical trial investigating whether combining a proven multidomain lifestyle intervention with a GLP-1 agonist can further reduce the risk of cognitive decline, mild cognitive impairment (MCI) and dementia in at-risk older adults.

– LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results — Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures –

July 13, 2026 /PRNewswire/ — The Alzheimer’s Association today announced the launch of the PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy), a first-of-its-kind global clinical trial designed to evaluate whether combining a proven multidomain lifestyle intervention with a metabolism-targeting drug, such as a GLP-1 agonist, can further reduce the risk of cognitive…

The psychiatric safety profile of glucagon-like peptide-1 receptor agonists (GLP-1RAs) is characterized by inconsistent findings during active treatment and remains largely unexplored after cessation. Here we show that GLP-1RA discontinuation is associated with an increased risk of psychiatric events. Using large-scale electronic health records from the Shanghai Hospital Link Database, we investigate incident depressive and…